HighTower Advisors LLC lessened its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 0.6% during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 207,243 shares of the medical equipment provider's stock after selling 1,308 shares during the period. HighTower Advisors LLC owned about 0.06% of Intuitive Surgical worth $102,641,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Chilton Capital Management LLC raised its position in shares of Intuitive Surgical by 614.3% during the 1st quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider's stock valued at $25,000 after purchasing an additional 43 shares during the period. Parvin Asset Management LLC purchased a new stake in Intuitive Surgical during the 4th quarter worth approximately $26,000. Global Financial Private Client LLC grew its position in shares of Intuitive Surgical by 253.3% during the 1st quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock valued at $26,000 after acquiring an additional 38 shares during the period. Elite Financial Inc. acquired a new stake in shares of Intuitive Surgical in the first quarter valued at about $26,000. Finally, LFA Lugano Financial Advisors SA purchased a new position in Intuitive Surgical during the first quarter worth about $30,000. Institutional investors own 83.64% of the company's stock.
Insider Activity at Intuitive Surgical
In related news, SVP Mark Brosius sold 216 shares of Intuitive Surgical stock in a transaction on Friday, June 6th. The shares were sold at an average price of $563.11, for a total value of $121,631.76. Following the sale, the senior vice president owned 907 shares of the company's stock, valued at approximately $510,740.77. This trade represents a 19.23% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Gary S. Guthart sold 7,893 shares of Intuitive Surgical stock in a transaction dated Monday, July 28th. The stock was sold at an average price of $498.64, for a total value of $3,935,765.52. Following the completion of the sale, the insider owned 13,187 shares in the company, valued at approximately $6,575,565.68. The trade was a 37.44% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 15,839 shares of company stock worth $7,896,972. Insiders own 0.70% of the company's stock.
Intuitive Surgical Price Performance
NASDAQ:ISRG traded up $3.18 during mid-day trading on Friday, reaching $480.26. 1,436,064 shares of the company's stock traded hands, compared to its average volume of 1,995,683. The company has a 50 day moving average price of $510.29 and a 200-day moving average price of $526.13. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00. The firm has a market capitalization of $172.16 billion, a price-to-earnings ratio of 66.98, a PEG ratio of 5.06 and a beta of 1.59.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, topping the consensus estimate of $1.93 by $0.26. The company had revenue of $2.44 billion during the quarter, compared to the consensus estimate of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. Intuitive Surgical's quarterly revenue was up 21.4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.78 EPS. As a group, analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.
Wall Street Analyst Weigh In
A number of equities research analysts recently issued reports on the stock. Truist Financial boosted their target price on shares of Intuitive Surgical from $590.00 to $600.00 and gave the company a "buy" rating in a report on Wednesday, July 23rd. Royal Bank Of Canada lifted their price objective on Intuitive Surgical from $605.00 to $615.00 and gave the stock an "outperform" rating in a report on Wednesday, July 23rd. Robert W. Baird decreased their price target on shares of Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating for the company in a research report on Wednesday, April 23rd. Erste Group Bank reissued a "hold" rating on shares of Intuitive Surgical in a research note on Wednesday, July 23rd. Finally, BTIG Research raised their target price on Intuitive Surgical from $566.00 to $571.00 and gave the company a "buy" rating in a research note on Wednesday, July 23rd. One analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have issued a buy rating to the stock. According to MarketBeat.com, Intuitive Surgical has an average rating of "Moderate Buy" and an average price target of $595.95.
Get Our Latest Stock Analysis on Intuitive Surgical
About Intuitive Surgical
(
Free Report)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Featured Stories

Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here

We are about to experience the greatest A.I. boom in stock market history...
Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.
That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.
- The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
- The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
- Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.
Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.
And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...
Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.